HW
THC icon

Hancock Whitney’s Tenet Healthcare THC Stock Holding History

Hancock Whitney’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7M Buy
89,244
+378
+0.4% +$69.5K 0.28% 90
2026
Q1 		$15.7M Sell
88,866
-3,069
-3% -$647K 0.27% 94
2025
Q4 		$18.3M Sell
91,935
-1,416
-2% -$286K 0.33% 93
2025
Q3 		$19M Sell
93,351
-10,783
-10% -$1.91M 0.34% 80
2025
Q2 		$18.3M Buy
104,134
+5,252
+5% +$791K 0.35% 84
2025
Q1 		$13.3M Buy
98,882
+17,036
+21% +$2.24M 0.43% 52
2024
Q4 		$10.3M Sell
81,846
-12,980
-14% -$1.93M 0.33% 65
2024
Q3 		$15.8M Buy
94,826
+60,453
+176% +$9.14M 0.51% 43
2024
Q2 		$4.57M Sell
34,373
-4,602
-12% -$554K 0.16% 110
2024
Q1 		$4.1M Sell
38,975
-372
-0.9% -$33.4K 0.14% 119
2023
Q4 		$2.97M Sell
39,347
-1,776
-4% -$113K 0.11% 150
2023
Q3 		$2.71M Sell
41,123
-4,914
-11% -$367K 0.11% 149
2023
Q2 		$3.75M Sell
46,037
-7,809
-15% -$556K 0.15% 120
2023
Q1 		$3.2M Buy
53,846
+28,038
+109% +$1.56M 0.13% 139
2022
Q4 		$1.26M Sell
25,808
-253,600
-91% -$11.7M 0.05% 279
2022
Q3 		$14.4M Sell
279,408
-10,259
-4% -$609K 0.62% 38
2022
Q2 		$15.2M Sell
289,667
-2,542
-0.9% -$177K 0.61% 39
2022
Q1 		$25.1M Sell
292,209
-14,588
-5% -$1.2M 0.85% 26
2021
Q4 		$25.1M Sell
306,797
-728
-0.2% -$53.2K 0.79% 26
2021
Q3 		$20.4M Buy
307,525
+455
+0.1% +$32.3K 0.71% 33
2021
Q2 		$20.6M Sell
307,070
-1,269
-0.4% -$78.7K 0.66% 29
2021
Q1 		$16M Buy
308,339
+239,434
+347% +$12.1M 0.54% 40
2020
Q4 		$2.75M Sell
68,905
-2,751
-4% -$88.8K 0.09% 202
2020
Q3 		$1.76M Buy
71,656
+40,342
+129% +$1.03M 0.06% 247
2020
Q2 		$567K Buy
+31,314
New +$617K 0.02% 486

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Hancock Whitney's THC Position: Q2 2026 in Review

Hancock Whitney increased its Tenet Healthcare (THC) stake by 0.43% in Q2 2026, buying an estimated $69.5K and bringing the position to 89,244 shares worth $16.7M. The position accounts for 0.28% of the portfolio, ranked #90.

Hancock Whitney first reported a position in THC in Q2 2020 and has held it in 25 quarters since. The position peaked at $25.1M in Q1 2022. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Hancock Whitney held 89,244 shares of Tenet Healthcare worth $16.7M as of Q2 2026.
  • Hancock Whitney bought 378 Tenet Healthcare shares in Q2 2026, an estimated $69.5K.
  • Tenet Healthcare made up 0.28% of Hancock Whitney's portfolio in Q2 2026, its #90 holding.
  • Hancock Whitney first reported a position in Tenet Healthcare in Q2 2020 and has held it in 25 quarters since.
  • Hancock Whitney's Tenet Healthcare position peaked at $25.1M in Q1 2022.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.